The Delafloxacin Meglumine Injection, cataloged under National Stock Number 6505-01-713-9568, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Melinta Therapeutics, Llc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-713-9568 |
| Primary Part Number | NDC70842-0102-03 |
| Item Name | Delafloxacin Meglumine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Melinta Therapeutics, Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC70842-0102-03 PRIMARY | Melinta Therapeutics, Llc (USA) |
| Reference | Meaning |
|---|---|
| 1656109 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM239276 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-713-9568 is a Delafloxacin Meglumine Injection, manufactured by Melinta Therapeutics, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-713-9568 has 1 manufacturer part number on file: NDC70842-0102-03 (Melinta Therapeutics, Llc).
Key specifications for NDC70842-0102-03: Special Features: DELAFLOXACIN MEGLUMINE INJECTION 300MG SINGLE DOSE VIALS, 10CT. MUST BE RECONSTITUTED AND FURTHER DILUTED, FOR INTRAVENOUS INFUSION ONLY. RECONSTITUTED VIALS, MAY BE STORED EITHER REFRIGERATED AT 2 C TO 8 C (36 F TO 46 F), OR AT CONTROLLED ROOM TEMPERATURE 20 C TO 25 C (68 F TO 77 F) FOR UP TO 24 HOURS. DO NOT FREEZE. ONCE DILUTED, MAY BE STORED EITHER REFRIGERATED AT 2 C TO 8 C (36 F TO 46 F) OR AT A CONTROLLED ROOM TEMPERATURE OF 20 C TO 25 C (68 F TO 77 F) FOR UP TO 24 HOURS.; Part Name Assigned by Controlling Agency: DELAFLOXACIN MEGLUMINE INJECTION 300MG SINGLE DOSE VIALS, 10CT. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.